Cocaine Vaccination works in 38% of subjects

Researchers at Bayer College of Medicine in Houston Texas have concluded the first part of Cocaine vaccination trials, and found the vaccine clinically effects 38% of subjects.

The vaccine uses the immune system to block the effects of cocaine and may be used in treating cocaine addiction – provided larger studies support the provisional idicators of effect and clinical safety.

It is not likely to be a treatment option for at least 3-5 years

Cocaine vaccine trial results look promising

A study in the USA on an experimental Cocaine vaccine for Cocaine addicts has shown promising results. The research was conducted at Yale University and published in the Journal of the American Medical Association.

While only a relatively small study the results suggested that this may be a way forward in the fight against drug addiction, and enabled some addicts to cut there drug useage.

Click here to visit BBC online and read more about this Cocaine vaccine

Click here for information on Cocaine Drug Testing